Fidelity Disrupt Medicin ETFFMEDETF
13F holders, Q4 2024 (December 31)8holders +1
0new positions
0sold out
$24.66avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, up 1 from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were FMR LLC ($16.3M), Wealth Enhancement Advisory Services, LLC ($14.4M) and Jane Street Group, LLC ($1.6M).
- Company
- Fidelity Disrupt Medicin ETF
- CUSIP
- 316092147
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 48,329 shares bought and 3,667 shares sold, net +44,662 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| FMR LLC | 0.00% | Reduce -0.5% | 660,364 | $16.3M |
| Wealth Enhancement Advisory Services, LLC | 0.03% | Add +8.1% | 583,615 | $14.4M |
| Jane Street Group, LLC | 0.00% | Add +7.4% | 65,883 | $1.6M |
| Park Square Financial Group, LLC | 0.01% | — | 589 | $15K |
| UBS Group AG | 0.00% | Reduce -67.2% | 210 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 162 | $4K |
| Central Pacific Bank - Trust Division | 0.00% | No change | 97 | $2K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 90 | $2K |
"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.